Falsely elevated serum vancomycin concentrations in hemodialysis patients

American Journal of Kidney Diseases

Volumn 27, Issue 1, 1996, Pages 67-74

  Follin, S L ^a   Mueller, B A ^a   Scott, M K ^a   Carfagna, M A ^a   Kraus, M A ^a  

^a Exempla Saint Joseph Hospital   (United States)

Author keywords

chronic kidney failure; drug monitoring; enzyme multiplied immunoassay technique; fluorescence polarization immunoassay; Vancomycin

Indexed keywords

CELLULOSE ACETATE; VANCOMYCIN;

ACCURACY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMODIALYSIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE;

EID: 0030039451     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90032-3     Document Type: Article

References (24)

1. CD Freeman R Quintiliani CH Nightingale Vancomycin therapeutic drug monitoring: Is it necessary? Ann Pharmacother 27 1993 594 598
2. RD Pryka Vancomycin serum concentration monitoring: A continued debate Ann Pharmacother 28 1994 1397 1399 (editorial)
3. TG Cantu NA Yamanaka-Yeun PS Lietman Serum vancomycin concentrations: Reappraisal of their clinical value Clin Infect Dis 18 1994 533 543
4. RC Moellering Monitoring serum vancomycin levels: Climbing the mountain because it is there? Clin Infect Dis 18 1994 544 546 (editorial)
5. WG Leader MHH Chandler M Castiglia Pharmacokinetic optimization of vancomycin therapy Clin Pharmacokinet 28 1995 327 342
6. LM Perino BA Mueller Accuracy of vancomycin serum concentrations in patients with renal failure Ann Pharmacother 27 1993 892 893
7. GD Morse DK Nairn JS Bertino JJ Walshe Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis Ther Drug Monit 9 1987 212 215
8. L Anne M Hu K Chan L Colin K Gottwald Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: Its detection in sera of renally impaired patients Ther Drug Monit 11 1989 585 591
9. K-T Yeo W Traverse GL Horowitz Clinical performance of the EMIT vancomycin assay Clin Chem 35 1989 1504 1507
10. MW Hu L Anne T Forni K Gottwald Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: Comparison of high-performance liquid chromatography, EMIT, and fluorescence polarization immunoassay methods Ther Drug Monit 12 1990 562 569
11. CM Paap GL Sharpe Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates Dev Pharmacol Ther 20 1993 174 179
12. CM Harris TM Harris Structure of the glycopeptide antibiotic vancomycin Evidence for an asparagine residue in the peptide ed 2 J Am Chem Soc 104 1982 4293 4295
13. CM Harris H Kopecka TM Harris Vancomycin: Structure and transformation to CDP-1 J Am Chem Soc 105 1983 6915 6922
14. LO White R Edwards HA Holt AM Lovering RG Finch DS Reeves The in-vitro degradation at 37°C of vancomycin in serum, CAPD fluid and phosphate-buffered saline J Antimicrob Chemother 22 1988 739 745
15. TJ Comstock DA Sica RE Fichtl J Davis Multicompartment vancomycin (V) kinetics in patients with end-stage renal disease (ESRD) Clin Pharmacol Ther 43 1988 172 (abstr)
16. CC Tan HS Lee TY Ti EJC Lee Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure Ther Drug Monit 12 1990 29 34
17. GR Matzke Vancomycin WE Evans JJ Schentag WJ Jusko Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring 1992 Applied Therapeutics Vancouver, WA 1 31
18. US Renal Data Systems ed 2 USRDS 1994 Annual Data Report July 1994 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
19. MY Munar IC Doyle MM Meyer Cyclosporin and vancomycin disposition during continuous venovenous hemodiafiltration Ann Pharmacother 29 1995 374 377
20. AE Zimmermann BG Katona KI Plaisance Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia Pharmacotherapy 15 1995 85 91
21. DM Lanese BA Molitoris Removal of vancomycin by hemodialysis: A significant and overlooked consideration Semin Dial 2 1989 73 74
22. B Bastani DA Spyker A Minocha R Cummings FB Westervelt In vivo comparison of three different hemodialysis membranes for vancomycin clearance: Cuprophan, cellulose acetate and polyacrylonitrile Dial Transplant 17 1988 527 543
23. DM Lanese PS Alfey BA Molitoris Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers Kidney Int 35 1989 1409 1412
24. CA DeSoi DF Sahm JG Umans Vancomycin elimination during high-flux hemodialysis: Kinetic model and comparison of four membranes Am J Kidney Dis 20 1992 354 360